Sinocare Past Earnings Performance
Past criteria checks 1/6
Sinocare has been growing earnings at an average annual rate of 8.3%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 21.2% per year. Sinocare's return on equity is 5.3%, and it has net margins of 5.3%.
Key information
8.3%
Earnings growth rate
9.2%
EPS growth rate
| Medical Equipment Industry Growth | 16.0% |
| Revenue growth rate | 21.2% |
| Return on equity | 5.3% |
| Net Margin | 5.3% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
We Think You Can Look Beyond Sinocare's (SZSE:300298) Lackluster Earnings
Nov 02
Sinocare's (SZSE:300298) Soft Earnings Don't Show The Whole Picture
May 02Recent updates
Is Sinocare (SZSE:300298) Using Too Much Debt?
Nov 17We Think You Can Look Beyond Sinocare's (SZSE:300298) Lackluster Earnings
Nov 02Estimating The Intrinsic Value Of Sinocare Inc. (SZSE:300298)
Oct 23Sinocare (SZSE:300298) Is Reinvesting At Lower Rates Of Return
Oct 03Sinocare Inc.'s (SZSE:300298) Price Is Out Of Tune With Earnings
Aug 07Calculating The Intrinsic Value Of Sinocare Inc. (SZSE:300298)
Jul 19Is Sinocare (SZSE:300298) A Risky Investment?
Jun 07Sinocare's (SZSE:300298) Soft Earnings Don't Show The Whole Picture
May 02Sinocare Inc.'s (SZSE:300298) P/E Is On The Mark
Apr 22Here's What To Make Of Sinocare's (SZSE:300298) Decelerating Rates Of Return
Apr 03Revenue & Expenses Breakdown
How Sinocare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 4,206 | 222 | 1,582 | 389 |
| 30 Jun 24 | 4,184 | 307 | 1,530 | 366 |
| 31 Mar 24 | 4,190 | 306 | 1,468 | 376 |
| 31 Dec 23 | 4,059 | 284 | 1,431 | 356 |
| 30 Sep 23 | 4,137 | 379 | 1,406 | 332 |
| 30 Jun 23 | 4,110 | 392 | 1,383 | 325 |
| 31 Mar 23 | 4,215 | 441 | 1,389 | 331 |
| 01 Jan 23 | 3,952 | 447 | 1,335 | 306 |
| 30 Sep 22 | 3,463 | 296 | 1,217 | 259 |
| 30 Jun 22 | 3,081 | 218 | 1,148 | 234 |
| 31 Mar 22 | 2,478 | 128 | 990 | 192 |
| 01 Jan 22 | 2,361 | 108 | 971 | 182 |
| 30 Sep 21 | 2,235 | 134 | 993 | 194 |
| 30 Jun 21 | 2,174 | 147 | 927 | 193 |
| 31 Mar 21 | 2,095 | 168 | 858 | 190 |
| 31 Dec 20 | 2,015 | 187 | 788 | 182 |
| 30 Sep 20 | 2,049 | 287 | 724 | 187 |
| 30 Jun 20 | 1,936 | 280 | 695 | 173 |
| 31 Mar 20 | 1,831 | 265 | 672 | 164 |
| 31 Dec 19 | 1,778 | 251 | 653 | 161 |
| 30 Sep 19 | 1,651 | 286 | 613 | 137 |
| 30 Jun 19 | 1,604 | 272 | 587 | 140 |
| 31 Mar 19 | 1,607 | 276 | 591 | 134 |
| 31 Dec 18 | 1,551 | 310 | 588 | 129 |
| 30 Sep 18 | 1,429 | 286 | 543 | 123 |
| 30 Jun 18 | 1,301 | 333 | 452 | 131 |
| 31 Mar 18 | 1,112 | 296 | 392 | 100 |
| 01 Jan 18 | 1,033 | 258 | 352 | 74 |
| 30 Sep 17 | 994 | 206 | 346 | 49 |
| 30 Jun 17 | 945 | 156 | 376 | 0 |
| 31 Mar 17 | 849 | 116 | 361 | 0 |
| 31 Dec 16 | 796 | 115 | 346 | 0 |
| 30 Sep 16 | 722 | 138 | 328 | 0 |
| 30 Jun 16 | 674 | 121 | 327 | 0 |
| 31 Mar 16 | 698 | 155 | 317 | 0 |
| 31 Dec 15 | 646 | 144 | 302 | 0 |
| 30 Sep 15 | 634 | 176 | 266 | 0 |
| 30 Jun 15 | 611 | 191 | 236 | 0 |
| 31 Mar 15 | 570 | 199 | 207 | 0 |
| 31 Dec 14 | 545 | 197 | 195 | 0 |
| 30 Sep 14 | 506 | 191 | 178 | 0 |
| 30 Jun 14 | 488 | 176 | 167 | 0 |
| 31 Mar 14 | 450 | 157 | 160 | 0 |
| 31 Dec 13 | 449 | 165 | 150 | 0 |
Quality Earnings: 300298 has a large one-off loss of CN¥115.8M impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: 300298's current net profit margins (5.3%) are lower than last year (9.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300298's earnings have grown by 8.3% per year over the past 5 years.
Accelerating Growth: 300298's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 300298 had negative earnings growth (-41.5%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.8%).
Return on Equity
High ROE: 300298's Return on Equity (5.3%) is considered low.